PDF herunterladen
Dtsch Med Wochenschr 2013; 138(04): 131-148
DOI: 10.1055/s-0032-1327255
CME | Review article
Hepatologie
© Georg Thieme Verlag KG Stuttgart · New York

Abklärung erhöhter Leberwerte

Differential diagnosis of abnormal liver function tests
M. J. Bahr
1   Medizinische Klinik I, Sana Kliniken Lübeck GmbH
› Institutsangaben
Weitere Informationen

Publikationsverlauf

02. Januar 2012

11. Oktober 2012

Publikationsdatum:
22. Januar 2013 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Schlüsselwörter

Leberwerte - Differenzialdiagnose - Hepatitis - Cholestase

Keywords

Liver function tests - Differential diagnosis - Hepatitis - Cholestasis
 

  • Literatur

  • 1 American Thoracic Society/European Respiratory Society Statement. Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168: 818-900
    CrossrefPubMedGoogle Scholar
  • 2 Bahr MJ. Nichtinvasive Leberfibrosebestimmung. Med Welt 2009; 60: 137-142
    PubMedGoogle Scholar
  • 3 Bahr MJ. Vascular liver disease. In: Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H, eds. Hepatology – A clinical textbook. 3rd. ed. Düsseldorf: Flying Publisher; 2012: 509-525
    Google Scholar
  • 4 Bahr MJ, Bantel H, Lichtinghagen R. Labordiagnostik. In: Bahr MJ, ed. Nichtinvasive Diagnostik bei Lebererkrankungen. Bremen: UNI-MED Verlag; 2011: 15-29
    Google Scholar
  • 5 Bahr MJ, Rifai K, Bantel H. Verhalten bei erhöhten Leberwerten. In: Bahr MJ, ed. Nichtinvasive Diagnostik bei Lebererkrankungen. Bremen: UNI-MED Verlag; 2011: 45-57
    Google Scholar
  • 6 Benckert J, Berg T. Diagnostik und Klinik der Infektion mit Hepatitis-A- und Hepatitis-E-Viren. Pharm Unserer Zeit 2011; 40: 25-29
    CrossrefPubMedGoogle Scholar
  • 7 Chapman R, Fevery J, Kalloo A et al. AASLD Practice Guidelines. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51: 660-671
    CrossrefPubMedGoogle Scholar
  • 8 Cornberg M, Protzer U, Petersen J et al. Aktualisierung der S3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion. Z Gastroenterol 2011; 49: 871-930
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 9 Dalton HR, Bendall R, Ijaz S et al. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8: 698-709
    CrossrefPubMedGoogle Scholar
  • 10 Dufour DR, Lott JA, Nolte FS et al. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000; 46: 2050-2068
    PubMedGoogle Scholar
  • 11 EASL Clinical Practice Guidelines. HFE hemochromatosis. J Hepatol 2010; 53: 3-22
    CrossrefPubMedGoogle Scholar
  • 12 Hadem J, Strassburg CP, Manns MP. Prediction of outcome and selection of the liver transplantat candidate in acute liver failure. Frontiers Physiol 2012; 3: 1-7
    PubMedGoogle Scholar
  • 13 Hennes EM, Zeniya M, Czaja AJ et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176
    CrossrefPubMedGoogle Scholar
  • 14 Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011; 378: 73-85
    CrossrefPubMedGoogle Scholar
  • 15 Kim WR, Flamm SL, Di Bisceglie AM et al. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008; 47: 1363-1370
    CrossrefPubMedGoogle Scholar
  • 16 Lazo M, Selvin E, Clark JM. Clinical implications of short-term variability in liver function test results. Ann Intern Med 2008; 148: 348-352
    CrossrefPubMedGoogle Scholar
  • 17 Lindor KD, Gershwin ME, Poupon R et al. AASLD Practice Guidelines. Primary biliary cirrhosis. Hepatology 2009; 50: 291-308
    CrossrefPubMedGoogle Scholar
  • 18 Manns MP, Czaja AJ, Gorham JD et al. AASLD Practice Guidelines. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-2213
    CrossrefPubMedGoogle Scholar
  • 19 Moss DW. Diagnostic aspects of alkaline phosphatase and its isoenzymes. Clin Biochem 1987; 20: 225-230
    CrossrefPubMedGoogle Scholar
  • 20 O’Shea RS, Dasarathy S, McCullough AJ et al. AASLD Practice Guidelines. Alcoholic liver disease. Hepatology 2010; 51: 307-328
    CrossrefPubMedGoogle Scholar
  • 21 Roberts EA, Schilsky ML. AASLD Practice Guidelines. Diagnosis and treatment of Wilson disease. Hepatology 2008; 47: 2089-2111
    CrossrefPubMedGoogle Scholar
  • 22 Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725
    CrossrefPubMedGoogle Scholar
  • 23 Sarrazin C, Berg T, Ross RS et al. Update der S3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion. Z Gastroenterol 2010; 48: 289-351
    Google Scholar
  • 24 Schirmacher P, Fleig WE, Tannapfel A et al. Bioptische Diagnostik der chronischen Hepatitis. Pathologe 2004; 25: 337-348
    PubMedGoogle Scholar
  • 25 Swain MG. Fatigue in liver disease: Pathophysiology and clinical management. Can J Gastroenterol 2006; 20: 181-188
    PubMedGoogle Scholar
  • 26 Vavricka SR, Burri E, Beglinger C et al. Serum protein electrophoresis: an underused but very useful test. Digestion 2009; 79: 203-210
    CrossrefPubMedGoogle Scholar
  • 27 Vergani D, Alvarez F, Bianchi FB et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004; 41: 677-683
    CrossrefPubMedGoogle Scholar
  • 28 Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263-355
    CrossrefPubMedGoogle Scholar